Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA

Medicare Prescription Drug Benefit Clinical Slides

 

Training Aid: PowerPoint Presentation

This slide set is intended for use in training clinicians on the Medicare Part D prescription drug benefit and its implications for HIV/AIDS programs, particularly for the Ryan White CARE Act.  The slides can be downloaded in PowerPoint (include Talking Points for trainers to use in presenting the material) or PDF132KB.

Slide 1: Medicare Part D and HIV/AIDS: What a Clinician May Want to Know
 

Laura Cheever, M.D., ScM
Deputy Director, Chief Medical Officer
HIV/AIDS Bureau Health Resources and Services Administration
Department of Health and Human Services

  Talking Points: None
 
Slide 2: Medicare and HIV/AIDS
 
  • Approximately 60,000-80,000 Medicare beneficiaries with HIV/AIDS
    • Qualify primarily through being on Social Security Disability Income (SSDI) for 2+ years
    • Currently no prescription benefit
  • 70-85% also qualify for Medicaid
    • ‘Dually eligible' or ‘dual eligibles'
    • Approximately 50,000-60,000 individuals
    • Medicaid currently provides prescription drug coverage
  Talking Points: None
 
Slide 3: Medicare Modernization Act (MMA)
 
  • Adds a prescription drug benefit to Medicare, known as Medicare Part D
    • Benefit starts January 1, 2006
    • Most Medicare beneficiaries must elect the benefit and choose a plan
    • Dual eligible beneficiaries will be automatically enrolled in Medicare Part D because prescription drug coverage will switch from Medicaid to Medicare January 1
    • Plan formularies must include all antiretrovirals
  Talking Points: None
 
Slide 4: Basic Plan: Beneficiary Cost
 
  • Monthly premium (around $32.20 in 2006)
  • $250 deductible
  • 25% coinsurance from $250 to $2,250*
  • 100% of drug costs from $2,251 to $5,100
  • Catastrophic coverage: co-pay of 5% or $2/$5 (whichever is greater) after total drug costs reached $5,100 and beneficiary has paid $3,600 in out-of-pocket costs

*Coinsurance is a term used in Medicare Part D that refers to the beneficiary's contribution toward prescription drug costs until the catastrophic coverage level has been reached.

  Talking Points: CMS is clear – unlike Medicaid, there's no right to the medication if the patient can't pay the co- pay.  An individual pharmacy may choose to waive the co-pay and such a waiver will count toward TrOOP, but the pharmacy can't advertise this benefit or publicize it in any way.
 
Slide 5 & 6: Low-Income Subsidies
 
  • Most Medicare beneficiaries with HIV/AIDS will qualify for some type of low-income subsidy
  • Dual eligibles, Medicare beneficiaries on Supplemental Security Income (SSI) or in a Medicare Savings Program (QMB, SLMB, QI) will automatically be eligible
  • Beneficiaries who aren't included in the group above but meet income and asset criteria need to apply to Social Security or Medicaid to qualify for a subsidy
  • Subsidy counts toward out-of-pocket costs and reaching catastrophic coverage level

Main Benefit and Low-Income Provisions

charts here

*Cost sharing is $0 if the beneficiary is on Medicaid and institutionalized.

  Talking Points: None
 
Slide 7: Case Study: Jane Matthews
 
  • On SSDI, Medicare and Medicaid (dual eligible)
  • SSDI benefit $780/month (less than100% FPL)
  • Antiretroviral regimen is efavirenz and FTC/TDF
  • Drugs cost $1,300 per month
  • Jane pays $6 in co-pays per month for two scripts (income < 100% FPL so $3 brand name co-pay applies) for three months
  • By 4 th month, total drug costs of $5,200 exceeds $5,100 catastrophic limit
  • No cost to Jane after that
  • Jane pays $18 for the year [3 months of $6 co-pay]
  Talking Points: ADAP could pay co-pays for Jane.
 
Slide 8: Case Study: Jason Smith
 
  • On SSDI, Medicare and small private disability insurance benefit
  • Income $1,100 per month (138% FPL)
  • Same drug regimen and costs
  • Jason pays:
    • About $8 per month in premiums (75% subsidy of $32.20)
    • Month 1: $50 deductible plus $187.50 (15% co-insurance of $1,250 balance)
    • Month 2: $195 coinsurance (15% coinsurance of $1,300)
    • Month 3: $195 coinsurance (total drug costs $3,900)
    • Month 4: $180 coinsurance (on $1200 balance of $5100 total drug cost limit for catastrophic coverage level)
    • Months 5-12: $10 per month ($5 brand name co-pay on two scripts)
  • Jason pays $983 for the year [$96 in premiums, $807.50 in deductible and co-insurance, $80 in co-pays]
  Talking Points: ADAP could pay premiums, deductible, co-insurance and co-pays for John.
 
Slide 9: Case Study: Peter Jones
 
  • 65 years old, HIV positive, aged into Medicare
  • Income $1,600 per month (200% FPL)
  • Same drug regimen and costs
  • Peter pays:
    • $32.20 per month in premiums
    • Month 1: $250 deductible plus $262 (25% coinsurance) towards $1050 balance
    • Month 2: $237 coinsurance (25% of $950 balance to reach $2250 co-insurance limit) plus $350 (balance of $1300 pharmacy cost)
    • Month 3: $1,300 prescription cost (100%) [Peter has now paid $2,399 out-of- pocket towards his drugs]
    • Month 4: $1,201 prescription cost (100% coinsurance for a total of $3,600 in out-of-pocket costs). Total drug costs are also above the $5,100 limit so the catastrophic coverage level has been reached.
    • Months 5-12: $65 per month (5% co-pay)
  • Peter pays $$4,506.40 for the year [$386.40 in premiums, $3600 out-of-pocket and $520 in co-pays]
  Talking Points: ADAP could pay premiums, deductible, co-insurance and co-pays for Bob.
 
Slide 10: Further Help With Costs
 
  • AIDS Drug Assistance Programs (ADAP), in accordance with State program policy, can pay:
    • Premiums
    • Deductible
    • Coinsurance (15%, 25% and 100%)
    • Co-pays
  • ADAP contributions do not count toward the $3,600 in out-of-pocket costs needed to reach the catastrophic coverage level
  Talking Points: None
 
Slide 11-13: Provider Role
 
  • June, 2005
    • Dual eligibles will get letters from Medicare telling them they will be auto-enrolled in Medicare Part D
    • Beneficiaries with low incomes may get letters from Social Security about applying for low income subsidies
  • You can:
    • Encourage Medicare patients to apply for subsidies
    • Tell dual eligibles to hold onto letters for their records
  • October, 2005
    • “Medicare and You” sent to all beneficiaries with plan information
    • Dual eligibles will get letters notifying them of the plan into which they are automatically enrolled
  • You can:
    • Encourage Medicare beneficiaries to enroll
    • Tell dual eligibles that they can choose a different plan
    • Refer patients to www.Medicare.gov or 1-800-Medicare
  • January 1, 2006
    • Dual eligible beneficiaries will receive drugs through Medicare plan
  • You can:
    • Prescribe extra antiretroviral medication to “bridge” transition period so that treatment regimen is uninterrupted
    • Ask about access to medication
  Talking Points: None

Centers for Medicare &
Medicaid Services Links

 

Medicare Prescription Drug Coverage General Information

Medicare Prescription Drug Benefits FAQs

Medicare.gov - the Official U.S. Government site for People with Medicare


Letters from HRSA
 

December 8, 2006 Letter to Grantees